Published 16 days ago

The court refused AstraZeneca to ban the Russian analogue of its cancer drug

Summary by RTVI

The Moscow Arbitration Court dismissed the claim filed by the British-Swedish pharmaceutical company AstraZeneca, which tried to deregister the Russian analogue of its cancer drug. RTVI found information about this in the file of arbitration cases.

0 Articles

All

Left

Center

Right

RTVI

The court refused AstraZeneca to ban the Russian analogue of its cancer drug

16 days ago·Moscow, Russian Federation

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.

Coverage Details

Total News Sources0

Leaning Left0Leaning Right0Center0Last Updated16 days agoBias Distribution

No sources with tracked biases.

Bias Distribution

There is no tracked Bias information for the sources covering this story.

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

The court refused AstraZeneca to ban the Russian analogue of its cancer drug

0 Articles

0 Articles

The court refused AstraZeneca to ban the Russian analogue of its cancer drug

The court refused AstraZeneca to ban the Russian analogue of its cancer drug

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics